Media

Jul 20, 2026 7:55 AM Eastern Daylight Time Immunomic Therapeutics Announces First Patient Dosed in Phase 1 Trial of Cancer Vaccine Candidate ITI-5000 Immunomic Therapeutics Announces First Patient Dosed in

Jun 15, 2026 7:55 AM Eastern Daylight Time ITI Announces PMDA Clearance of CTN for a UNITE®-Based Self-Amplifying RNA Treatment for Japanese Red Cedar Allergy Company to Initiate First-in-Human Phase

Jan 20, 2026 12:03 PM Eastern Standard Time Immunomic Therapeutics Announces FDA Clearance of IND Application for a UNITE®-Based Self-Amplifying RNA Vaccine for Triple-Negative Breast Cancer, to Be Studied Alone

November 18-22, 2026 Austin, TX

November 4-8, 2026 Phoenix, AZ

June 22-25, 2026 San Diego, CA

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meetings of their kind across the globe

The Alliance for mRNA Medicines (AMM) brings together senior executives and top decision-makers in the mRNA industry to advance pioneering research into vaccines and therapies for patients. The annual meeting, AMM

Save the date!

Make your mark at the largest cancer immunotherapy conference and exhibit at SITC’s 40th Anniversary Annual Meeting, hosted by the leading member-driven organization focused on cancer immunotherapy, SITC. At SITC’s Annual Meeting,

The 2025 ASCO Annual Meeting Program will feature over 200 sessions complementing Dr. Robin Zon's Presidential theme, Driving Knowledge to Action: Building a Better Future. #ASCO25 is The Place to Be Inspired